Tufts Center for the Study of Drug Development Offers Training to Increase R&D Efficiency; Set for Feb. 7–11 in Boston
November 29, 2004

Follow–On Drugs Improve Patient Safety and Help Reduce Costs
November 9, 2004

FDA, Pfizer Inc, & Institute for OneWorld Health to Address Need for New Drugs to Treat Neglected Diseases
September 27, 2004

Cost Considerations Increasingly Drive U.S. Formulary and Clinical Guidelines
September 8, 2004

Postmarketing Studies Becoming Essential to New Drug Development in the U.S.
July 6, 2004

Therapeutic Class Is a Critical Determinant of Drug Development Cost and Time
April 29, 2004

Time Required to Approve New European Biotech Products Matches U.S.
March 4, 2004

Training Offered to Increase Efficiency of New Drug Development
February 24, 2004

Pace of Switching Drugs from Prescription to Over–the–Counter Status Will Increase
January 27, 2004

Biotech Firms Will Speed Development of More Cancer Medicines
January 20, 2004

FDA Will Be Pressed to Do More with Less
January 13, 2004

Drug Companies Will Look to Joint Ventures to Cut R&D Costs
January 6, 2004